Relispray Natural Pain Relief Aerosol, Spray
NDC Package 46063-101-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Relispray Natural Pain Relief (menthol) aerosols is adults and children 12 years of age & older: spray on to affected area not more than 3 to 4 times daily; massage not necessary.Children under 12 years of age: consult a physicianWash hands after use with cool water. This formulation utilizes a aerosol, spray delivery system. Marketed by Midas-care Pharmaceuticals, Pvt. Ltd, this product is identified by NDC 46063-101 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
46063-101-11
Package Description
112 g in 1 BOTTLE, SPRAY
Product Code
46063-101
11-Digit Billing Format
46063010111
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Relispray Natural Pain Relief
Non-Proprietary Name
Menthol
Substance Name
Menthol, Unspecified Form
Dosage Form
Aerosol, Spray - An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
MENTHOL, UNSPECIFIED FORM 4 g/100g
Usage Information
Adults and children 12 years of age & older: spray on to affected area not more than 3 to 4 times daily; massage not necessary.Children under 12 years of age: consult a physicianWash hands after use with cool water

Regulatory & Marketing

Labeler Name
Midas-care Pharmaceuticals, Pvt. Ltd
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-05-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 46063-101-11 identifies a specific commercial package of 112 g in 1 bottle, spray of Relispray Natural Pain Relief, a human over the counter drug labeled by Midas-care Pharmaceuticals, Pvt. Ltd. This aerosol, spray is formulated for topical use and contains menthol, unspecified form as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Midas-care Pharmaceuticals, Pvt. Ltd on November 05, 2025. The current certification is valid through December 31, 2026.

How is this Midas-care Pharmaceuticals, Pvt. Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 46063010111. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
46063-101-11
11-Digit CMS (5-4-2)
46063-0101-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.